Source: Antimicrobial Agents and Chemotherapy. Unidade: IFSC
Subjects: STAPHYLOCOCCUS (ESTUDO), GENES, RNA, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUI, Longzhu et al. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, v. 54, n. 12, p. 5222-5233, 2010Tradução . . Disponível em: https://doi.org/10.1128/AAC.00437-10. Acesso em: 31 out. 2024.APA
Cui, L., Isii, T., Fukuda, M., Ochiai, T., Neoh, H. -min, Camargo, I. L. B. da C., et al. (2010). An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 54( 12), 5222-5233. doi:10.1128/AAC.00437-10NLM
Cui L, Isii T, Fukuda M, Ochiai T, Neoh H-min, Camargo ILB da C, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus [Internet]. Antimicrobial Agents and Chemotherapy. 2010 ; 54( 12): 5222-5233.[citado 2024 out. 31 ] Available from: https://doi.org/10.1128/AAC.00437-10Vancouver
Cui L, Isii T, Fukuda M, Ochiai T, Neoh H-min, Camargo ILB da C, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus [Internet]. Antimicrobial Agents and Chemotherapy. 2010 ; 54( 12): 5222-5233.[citado 2024 out. 31 ] Available from: https://doi.org/10.1128/AAC.00437-10